Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Hisamitsu describes platelet aggregation inhibitors

Sep. 6, 1996

Antiplatelet agents described by Kissei

Aug. 30, 1996

TxA2/PGH2 antagonists described by Terumo

Aug. 30, 1996

Fibrinogen antagonists claimed by Thomae

Aug. 30, 1996

Fibrinogen antagonists from Nippon Steel

Aug. 30, 1996

Glaxo Wellcome claims fibrinogen antagonists

Aug. 30, 1996

Fujisawa obtains marketing rights for ReoPro

Aug. 30, 1996

Terumo claims antithrombotic/antiallergy agents

Aug. 23, 1996

Fibrinogen antagonists in SmithKline Beecham's pipeline

Aug. 23, 1996

Corvas describes Factor Xa inhibitors

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...